Virginia Escamilla Gómez

Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study

Virginia Escamilla Gómez, Valentín García‐Gutiérrez, Lucía López‐Corral et al. · Bone Marrow Transplantation · 2019 · 90 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +7

Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial

Francisco Moniche, Juan Antonio Cabezas-Rodriguez, Roberto Valverde et al. · The Lancet Neurology · 2023 · 30 citations

Medicine, Neurology, Cell Therapy +11

Obecabtagene Autoleucel (obe-cel, AUTO1) for Relapsed/Refractory Adult B-cell Acute Lymphoblastic Leukemia (R/R B-ALL): Pooled Analysis of the Ongoing FELIX Phase Ib/II Study

Claire Roddie, Karamjeet Sandhu, Eleni Tholouli et al. · Blood · 2023 · 14 citations

Medicine, Hematology, Oncology +13

Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: outcome and prognostic factors. The Chronic Myeloid Leukemia Subcommittee of the GETH (Grupo Español de Trasplante Hemopoyético)

Virginia Escamilla Gómez, Ján Tomáš, Ricardo Parody et al. · Bone Marrow Transplantation · 2005 · 11 citations

Medicine, Hematology, Oncology +17

Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib

Alfonso Rodríguez‐Gil, Virginia Escamilla Gómez, Melanie Nufer et al. · Scientific Reports · 2022 · 10 citations · Full text

Life Sciences, Hematology, Immunology +15